Search filters

List of works by Gerardo Musuraca

A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma

scientific article

A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.

scientific article

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia

scientific article published on January 2011

Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report

scientific article published on 9 June 2015

CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies.

scientific article published on 26 June 2018

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.

scientific article

Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.

scientific article published on 9 June 2006

Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas

scientific article published in December 2005

Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients

scientific article published on May 2003

Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).

scientific article

Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma

scientific article

High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience

scientific article published on 01 May 2003

High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience

scientific article published in February 2004

Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma

scientific article published in June 2007

IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia

scientific article published on 15 July 2015

Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays

scientific article published on 01 March 2005

Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients

scientific article published on 24 August 2010

Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience

scientific article published on 06 September 2021

Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.

scientific article published in March 2004

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia

scientific article

Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma

scientific article

Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients

scientific article published on August 2004

Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma

scientific article published in January 2007

Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma

scientific article published in November 2008

Prolonged 18FDG-PET negative complete remission in a heavily pretreated, elderly patient with diffuse large B cell lymphoma treated with lenalidomide, low dose dexamethasone, and colony stimulating factor (Rd-G)

scientific article published on 15 October 2010

Rituximab plus Bendamustine as front line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin's lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi.

scientific article

Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma

scientific article published on 9 March 2009

VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly

scientific article published in November 2007

Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma

scientific article

Paulina is supported by:

About Paulina

Help